Dedicated GLP-1 trackers beat generalists on everything that surrounds the medication: dose timing, injection sites, symptom severity beside doses, and estimated medication levels
Serious but rare risks include pancreatitis and gallbladder disease, which require urgent medical attention
In the 12 months after an index event, 1.5% of patients with nonfatal MI and 0.5% with nonfatal stroke initiated a GLP-1, the two most common being semaglutide (Wegovy, Novo Nordisk) and liraglutide, followed by dulaglutide (Trulicity, Eli Lilly)
Ipamorelin is one of the most talked-about growth-hormone (GH) peptides in the research community, and for a simple reason: it is engineered to be clean
These extensive, global, multi-year studies were designed to rigorously assess whether oral semaglutide could decelerate the progression of early stage symptomatic AD in over 3,800 participants (Scheltens et al., 2026)